Delivery Order SPE2DB22D3301-SPE2DB25FX9UT
Award Date
2/10/25
Potential Completion Date
3/4/25
Potential Value
$30K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,462.92 firm fixed-price delivery order is for the supply of GAMUNEX-C 40 GRAM/400 ML VIAL 400 ML medical products. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,394.46, is for the delivery of GAMUNEX-C 20 gram/200 ML vials. The contract has a firm fixed price pricing type and an ultimate completion date of December 13, 2024. The contract was awarded on November 21, 2024 and was not set aside for any specific business type. AmerisourceBergen...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a major pharmaceutical distributor, a delivery order contract worth $49,752.80 for the supply of GAMUNEX-C 40 gram/400 ml vials. The contract has a firm fixed price and an ultimate completion date of January 6, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,325.64 firm fixed-price delivery order is for the supply of GAMUNEX-C 10 gram/100 ml vials and has an ultimate completion date of January 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, worth $20,942.80, is for the delivery of GAMUNEX-C 20 gram/200 mL vials. This is a firm fixed-price delivery order contract with an ultimate completion date of February 5, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,731.46 firm fixed-price contract is for the supply of GAMUNEX-C 10 gram/100 ml vials, with a completion date of December 30, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GAMUNEX-C 20 gram/200 ml vials. The $44,366.76 fixed-price contract has a period of performance through December 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies, including...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $115,417.92 firm-fixed-price contract is for the supply of GAMUNEX-C 40 gram/400 mL vials, a specialized immunoglobulin medication. The contract has an ultimate completion date of September 11, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has an award value of $26,849.76 and is a Firm Fixed Price Delivery Order for the supply of GAMUNEX-C 20 GRAM/200 ML VIAL 200ML. The contract has an ultimate completion date of February 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of GAMUNEX-C 5 gram/50 ml vial. The order has a firm fixed price of $2,959.30 and a period of performance through September 30, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to deliver a...